Mohale Thabo, Wolter Nicole, Allam Mushal, Ndlangisa Kedibone, Crowther-Gibson Penny, du Plessis Mignon, von Gottberg Anne
Centre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
BMC Genomics. 2016 Jun 22;17:470. doi: 10.1186/s12864-016-2808-x.
The capsular polysaccharide is the principal virulence factor of Streptococcus pneumoniae and a target for current pneumococcal vaccines. However, some pathogenic pneumococci are serologically nontypeable [nontypeable pneumococci (NTPn)]. Due to their relative rarity, NTPn are poorly characterized, and, as such, limited data exist which describe these organisms. We aimed to describe disease and genotypically characterize NTPn causing invasive pneumococcal disease in South Africa.
Isolates were detected through national, laboratory-based surveillance for invasive pneumococcal disease in South Africa and characterized by whole genome analysis. We predicted ancestral serotypes (serotypes from which NTPn may have originated) for Group I NTPn using multilocus sequence typing and capsular region sequence analyses. Antimicrobial resistance patterns and mutations potentially causing nontypeability were identified. From 2003-2013, 39 (0.1 %, 39/32,824) NTPn were reported. Twenty-two (56 %) had partial capsular genes (Group I) and 17 (44 %) had complete capsular deletion of which 15 had replacement by other genes (Group II). Seventy-nine percent (31/39) of our NTPn isolates were derived from encapsulated S. pneumoniae. Ancestral serotypes 1 (27 %, 6/22) and 8 (14 %, 3/22) were most prevalent, and 59 % (13/22) of ancestral serotypes were serotypes included in the 13-valent pneumococcal conjugate vaccine. We identified a variety of mutations within the capsular region of Group I NTPn, some of which may be responsible for the nontypeable phenotype. Nonsusceptibility to tetracycline and erythromycin was higher in NTPn than encapsulated S. pneumoniae.
NTPn are currently a rare cause of invasive pneumococcal disease in South Africa and represent a genetically diverse collection of isolates.
荚膜多糖是肺炎链球菌的主要毒力因子,也是当前肺炎球菌疫苗的作用靶点。然而,一些致病性肺炎球菌在血清学上无法分型[不可分型肺炎球菌(NTPn)]。由于它们相对罕见,对NTPn的特征了解甚少,因此描述这些微生物的数据有限。我们旨在描述南非导致侵袭性肺炎球菌疾病的NTPn的疾病情况并对其进行基因分型。
通过南非全国基于实验室的侵袭性肺炎球菌疾病监测检测分离株,并通过全基因组分析进行特征描述。我们使用多位点序列分型和荚膜区域序列分析预测了I组NTPn的祖先血清型(NTPn可能起源的血清型)。确定了抗菌药物耐药模式和可能导致不可分型的突变。2003年至2013年,报告了39株(0.1%,39/32824)NTPn。22株(56%)有部分荚膜基因(I组),17株(44%)有完整的荚膜缺失,其中15株被其他基因取代(II组)。我们的NTPn分离株中有79%(31/39)源自包膜肺炎链球菌。祖先血清型1(27%,6/22)和8(14%,3/22)最为常见,59%(13/22)的祖先血清型是13价肺炎球菌结合疫苗中包含的血清型。我们在I组NTPn的荚膜区域内鉴定了多种突变,其中一些可能导致不可分型表型。NTPn对四环素和红霉素的不敏感性高于包膜肺炎链球菌。
目前,NTPn是南非侵袭性肺炎球菌疾病的罕见病因,代表了一组基因多样的分离株。